These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2010909)

  • 1. Influence of soluble haemagglutinins on adherence of Helicobacter pylori to HEp-2 cells.
    Armstrong JA; Cooper M; Goodwin CS; Robinson J; Wee SH; Burton M; Burke V
    J Med Microbiol; 1991 Mar; 34(3):181-7. PubMed ID: 2010909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
    Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP
    Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble and cell-associated haemagglutinins of Helicobacter (Campylobacter) pylori.
    Robinson J; Goodwin CS; Cooper M; Burke V; Mee BJ
    J Med Microbiol; 1990 Dec; 33(4):277-84. PubMed ID: 2258915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence of Helicobacter pylori to human gastric epithelial cells in vitro.
    Hemalatha SG; Drumm B; Sherman P
    J Med Microbiol; 1991 Oct; 35(4):197-202. PubMed ID: 1941988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemagglutination profiles of Helicobacter species that cause gastritis in man and animals.
    Taylor NS; Hasubski AT; Fox JG; Lee A
    J Med Microbiol; 1992 Nov; 37(5):299-303. PubMed ID: 1279175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts.
    Stratton CW; Warner RR; Coudron PE; Lilly NA
    J Antimicrob Chemother; 1999 May; 43(5):659-66. PubMed ID: 10382887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Helicobacter pylori binding site on HEp-2 cells and three cell lines from human gastric carcinoma.
    Nishihara K; Nozawa Y; Nomura S; Kitazato K; Miyake H
    Fundam Clin Pharmacol; 1999; 13(5):555-61. PubMed ID: 10520728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
    Bland MV; Ismail S; Heinemann JA; Keenan JI
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of invasion frequencies of cultured HEp-2 cells by clinical isolates of Helicobacter pylori using an acridine orange assay.
    Wilkinson SM; Uhl JR; Kline BC; Cockerill FR
    J Clin Pathol; 1998 Feb; 51(2):127-33. PubMed ID: 9602686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono and dual therapy for Helicobacter pylori associated gastritis.
    Gill HH; Desai HG; Mehta PR; Ranganathan S; Kalro RH; Murti PK; Prabhu SR
    J Assoc Physicians India; 1991 Oct; 39(10):743-5. PubMed ID: 1816196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence of Helicobacter pylori to HEp-2 cells.
    Figueroa G; Portell DP; Soto V; Troncoso M
    J Infect; 1992 May; 24(3):263-7. PubMed ID: 1602147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
    Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
    Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and internalization of Helicobacter pylori by HEp-2 cells.
    Evans DG; Evans DJ; Graham DY
    Gastroenterology; 1992 May; 102(5):1557-67. PubMed ID: 1568565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
    Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H
    J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of Helicobacter pylori to abiotic surfaces is influenced by serum.
    Williams JC; McInnis KA; Testerman TL
    Appl Environ Microbiol; 2008 Feb; 74(4):1255-8. PubMed ID: 18156334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
    Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
    J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attachment, ingestion and intracellular killing of Helicobacter pylori by human peripheral blood mononuclear leukocytes and mouse peritoneal inflammatory macrophages.
    Chmiela M; Paziak-Domanska B; Wadström T
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):307-16. PubMed ID: 7773248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.